文献速递免疫规划

与Men-B疫苗同时接种可提高轮状病毒疫苗接种覆盖率:一项为期5年的区域回顾性队列研究(STORM研究)

Co-administration with Men-B vaccine increases Rotavirus vaccination coverage: A 5-year regionwide retrospective cohort study (STORM study).
PubMed 文献 · Vaccine · 2023-12-09

该研究利用意大利坎帕尼亚地区2016年1月至2020年12月出生的224,110名儿童疫苗接种登记数据,分析轮状病毒疫苗(RVV)与MenB疫苗同时接种对RVV覆盖率的影响。结果显示,同时接种RV/MenB疫苗的儿童完成RVV全程接种的比例显著高于单独接种RVV者(94.78% vs 72.26%,PR 1.275,95%CI 1.245-1.295,P<0.00001)。作者认为同时接种MenB疫苗可能有助于提高RVV覆盖率,尤其对五价轮状病毒疫苗,但需进一步安全性数据支持。

要点

  • 2016至2020年坎帕尼亚地区儿童RVV全程接种率从1.15%升至56.92%。
  • 同时接种RV/MenB疫苗者完成RVV全程的比例为94.78%,单独接种RVV者为72.26%(PR 1.275)。
  • 五价RVV同时接种的PR为1.288,高于单价RVV的PR 1.115。

核心结论

  • 尽管仍远未达到目标,坎帕尼亚地区RVV覆盖率近年有所增加;同时接种MenB疫苗可能有助于提高RVV覆盖率,尤其对五价RVV,但需进一步安全性数据支持将同时接种作为提高覆盖率的关键工具。

研究设计与样本

  • 本研究为基于区域疫苗接种登记系统的监测研究(STORM研究),纳入2016年1月至2020年12月出生于坎帕尼亚地区并接种第一年计划疫苗的儿童,共224,110名。

主要发现

  • 在224,110名儿童中,60,614名(27.0%)完成RVV全程接种,接种率从2016年的1.15%上升至2020年的56.92%。
  • 分别有6%的研究人群首剂和末剂RVV接种时间超出推荐时间。
  • RV疫苗与MenB疫苗同时接种的比例从2016年的0.7%上升至2020年的46.85%。
  • 同时接种RV/MenB疫苗的儿童完成RVV全程接种的比例为94.78%,单独接种RVV者为72.26%(PR 1.275,95%CI 1.245-1.295,P<0.00001)。
  • 同时接种对五价RVV的PR为1.288,对单价RVV的PR为1.115,调整混杂变量(接种年份、地区、性别)后结果一致。

关键数值与推荐

  • 同时接种RV/MenB疫苗者完成RVV全程接种的比例为94.78%,单独接种RVV者为72.26%,PR 1.275(95%CI 1.245-1.295,P<0.00001)。
  • 五价RVV同时接种的PR为1.288,单价RVV同时接种的PR为1.115。

临床怎么用

  • 作者认为同时接种MenB疫苗可能有助于提高RVV覆盖率,尤其对五价RVV,但需进一步安全性数据支持。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: In Italy Rotavirus vaccination (RVV) is provided free of charge from 2018, however, the coverage is scattered and suboptimal. The narrow time frame to complete the schedule is a barrier to uptake, and co-administration with other vaccines may potentially increase the coverage. Although the co-administration of RV vaccine and Meningococcal Group B vaccine (MenB) is not included in the product labels, we aimed at studying its impact on RVV coverage. METHODS: This Surveillance study on Timing and cOverage of Rotavirus and MenB vaccine co-administration (STORM study) used the Regional Vaccination Registry to collect data about children born in Campania Region between January 2016 and December 2020, and receiving vaccines scheduled in the first year of life. RESULTS: Among the 224,110 children enrolled, 60,614 (27.0%) completed the RVV schedule, with a vaccination rate that increased over time from 1.15% in 2016 to 56.92% in 2020. The first and last dose of RVV schedule were administered beyond the recommended time in 6% of the study population, respectively. Co-administration of RV vaccine with MenB vaccine increased from 0.7 % in 2016 to 46.85 % in 2020. Children receiving RV/MenB vaccines concomitantly had a significantly higher chance of completing the RV schedule compared to those receiving RVV alone during a specific appointment (94.78 % vs 72.26 %, Prevalence Ratio -PR- 1.275, 95 %CI 1.245-1.295p < 0.00001). The positive driving effect of RV/MenB co-administration was more evident for children receiving pentavalent (PR 1.288) than monovalent RVV (PR 1.115) which was confirmed when adjusted for confounding variables (i.e., year of vaccination, local district, gender). CONCLUSIONS: Although still far from the target, RVV coverage has increased in recent years in Campania Region. Co-administration with MenB vaccine may aid in increasing RVV coverage, especially for pentavalent RVV. Further safety data are needed to support co-administration as a key tool to increase coverage.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lo Vecchio A, Scarano SM, Palladino R, et al. Co-administration with Men-B vaccine increases Rotavirus vaccination coverage: A 5-year regionwide retrospective cohort study (STORM study). Vaccine. 2023. PMID: 38072758. doi:10.1016/j.vaccine.2023.12.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。